Voluntary Improvement Program News Today

On April 17, the Food and Drug Administration's Center for Devices and Radiological Health (CDRH) issued its 2024 safety report. As an update to their 2018 Medical Device Safety Action Plan...

New guidance to advance medical device safety, regulatory oversight, and innovation On April 17, the Food and Drug Administrations Center for Devices and Radiological Health ...

This guidance describes FDA’s participation in the Voluntary Improvement Program (VIP). The VIP is a voluntary program intended to guide improvement to enhance the quality of devices.

The FDA seeks comments on its proposed guidance describing its policy regarding FDA's participation in the Voluntary Improvement Program. The...

The FDA seeks comments on its proposed guidance describing its policy regarding FDA's participation in the Voluntary Improvement Program. The...

The Voluntary Improvement Program (VIP), through the Medical Device Innovation Consortium (MDIC), evaluates the capability and performance of a medical device manufacturer’s practices using third-party appraisals.

On May 5, 2022, the FDA’s Center for Devices and Radiological Health (CDRH) issued draft guidance regarding the FDA’s Voluntary Improvement Program (“VIP”). The draft guidance,...

FDA highlights key opportunities offered by VIP, which leverages ISACA’s Medical Device Discovery Appraisal Program (MDDAP)SCHAUMBURG, Ill.--(BUSINESS WIRE)--The Voluntary Improvement Program (VIP) has become the first Case for Quality program recognized by the United States Food and Drug Administration (FDA) throug...